ARTICLE | Company News
Infectious disease company Emergent BioSolutions Inc. (NYSE:EBS) said it purchased second-generation smallpox vaccine ACAM2000 from Sanofi (Euronext:SAN; NYSE:SNY) for $97.5 million in cash upfront and up to $27.5 million in near-term regulatory and manufacturing-related milestones. The deal does not include royalties. ...